Best Peptides for
Weight Loss
From GLP-1 drugs losing 25% body weight in clinical trials to GH peptides that burn fat while building muscle — the peptide landscape for weight loss in 2026 is more powerful than ever. Here's the complete comparison.
Find Your Peptide Protocol
Answer 4 quick questions to get a personalized recommendation based on your goal, experience, and preferences.
Weight Loss Peptide Selector
Answer 4 questions to get your personalized peptide recommendation.
Primary Goal
Three Ways Peptides Drive Fat Loss
Not all weight loss peptides work the same way. Understanding the mechanism helps you choose the right one.
Appetite Suppression
GLP-1 receptor agonists (semaglutide, tirzepatide, retatrutide) suppress hunger hormones and slow gastric emptying — dramatically reducing caloric intake without willpower.
GH-Driven Lipolysis
Growth hormone directly activates hormone-sensitive lipase in fat cells, mobilizing stored triglycerides for oxidation. CJC-1295 Ipamorelin amplifies your natural GH pulse 8–10×.
Muscle Preservation
IGF-1 LR3 and GH peptides preserve and build lean mass during fat loss — the key to avoiding the "skinny fat" outcome common on GLP-1 monotherapy.
GLP-1 Peptides vs. GH Peptides: The Full Comparison
The two major categories of weight loss peptides work through fundamentally different mechanisms, produce different kinds of fat loss, and suit different types of people. Understanding this distinction is the most important decision in building a peptide fat loss protocol.
How GLP-1 Peptides Work
GLP-1 (glucagon-like peptide-1) is a hormone naturally secreted by L-cells in the small intestine in response to food consumption. It signals the pancreas to release insulin, tells the stomach to slow gastric emptying, and — most critically for weight loss — activates satiety receptors in the hypothalamus to suppress appetite. GLP-1 receptor agonists (semaglutide, tirzepatide, retatrutide) mimic this hormone at supraphysiological levels, creating a persistent state of reduced appetite and improved insulin signaling.
The mechanism of action for tirzepatide expands this further: it also agonizes GIP (glucose-dependent insulinotropic polypeptide) receptors, which independently improve insulin secretion, reduce glucagon (the fat-storing signal), and appear to enhance the GLP-1 effect synergistically. Retatrutide adds glucagon receptor agonism to further increase metabolic rate, explaining its superior weight loss outcomes in Phase II trials.
How GH Peptides Work
Growth hormone secretagogues (CJC-1295, Ipamorelin, GHRP-6) work by stimulating the pituitary gland to produce more of your own growth hormone during natural secretion pulses — primarily during deep sleep. GH is directly lipolytic: it binds GH receptors on adipocytes and activates hormone-sensitive lipase, which hydrolyzes stored triglycerides into free fatty acids available for oxidation. Simultaneously, GH signals the liver to produce IGF-1, which drives muscle protein synthesis and satellite cell activation.
The fat loss from GH peptides is qualitatively different from GLP-1 fat loss. GLP-1s produce fat loss through reduced caloric intake (appetite suppression). GH peptides produce fat loss through increased fat oxidation — your body burns more fat even at the same caloric intake. This distinction matters enormously for body composition: GH-driven fat loss preferentially removes visceral and subcutaneous fat while adding lean muscle, producing a very different aesthetic result than GLP-1 monotherapy.
Who Needs Which
The volume of fat to lose exceeds what GH peptides can realistically achieve in a reasonable timeline. GLP-1s produce dramatic caloric restriction that accelerates fat loss significantly. Add CJC/Ipa after reaching 25–28% BF to protect lean mass and improve sleep.
Athletes and people seeking body recomposition benefit more from GH secretagogues. The goal is not just less weight — it's more muscle and less fat simultaneously. GLP-1s, used alone, cause lean mass loss that is counterproductive for this population.
Metabolic syndrome and insulin resistance respond immediately and powerfully to GLP-1 agonists — improving glucose metabolism, reducing visceral fat, and dramatically improving cardiovascular risk markers. After metabolic normalization (3–6 months), adding GH secretagogues enhances body composition further.
The Ultimate Cut: Stacking GLP-1 + GH Peptides
The most sophisticated fat loss protocol combines both categories. Semaglutide or tirzepatide drives the caloric deficit through appetite suppression. CJC-1295/Ipamorelin protects lean mass and improves sleep quality. IGF-1 LR3 added in 4-week cycles provides direct anti-catabolic signaling. MOTS-c rounds out the stack with metabolic optimization via AMPK activation.
This combination addresses every pathway of fat loss simultaneously — caloric reduction, fat mobilization, muscle preservation, sleep quality, and metabolic rate — and produces significantly superior results to either category alone. The main limitation is complexity and cost: running 3–4 peptides simultaneously requires more knowledge and higher monthly spend (~$200–350/month combined).
Cost and Side Effect Comparison
| Category | GLP-1 Peptides | GH Peptides |
|---|---|---|
| Monthly cost (research) | $80–180/month | $60–120/month |
| Primary side effects | Nausea (30–40%), constipation, fatigue | Mild water retention (temporary), hunger increase |
| Serious risks | Pancreatitis (rare), thyroid monitoring advised | Extremely rare with correct dosing |
| Injection frequency | Once weekly | Daily (before bed) |
| GI effects | Significant at start; improves over weeks | Minimal |
| Sleep effects | Neutral to slightly positive | Dramatically positive (deep sleep improvement) |
Fat Loss Without Muscle Loss: The Protein Protocol
The single biggest mistake in peptide-assisted weight loss is neglecting protein intake. Research consistently shows that 25–40% of total weight loss on GLP-1 monotherapy is lean mass, not fat. At high deficit levels, this means losing significant muscle alongside fat — producing a "smaller but softer" result rather than the lean, defined physique most people want.
Minimum Protein Requirements During Fat Loss
The research consensus for muscle preservation during caloric deficit is 1.6–2.2g of protein per kg of bodyweight (0.73–1.0g per lb). This range represents what muscle tissue requires to prevent breakdown when calories are restricted. At the higher end of this range (2.0–2.2g/kg), studies show near-complete muscle preservation even during aggressive deficits of 500–750 kcal/day.
Why Peptides Reduce the Muscle-Sparing Protein Requirement
GH peptides (CJC-1295/Ipamorelin) directly reduce the protein intake needed to preserve muscle during a cut. Growth hormone is anti-catabolic — it suppresses muscle protein breakdown at the signaling level by reducing the catabolic cytokines (myostatin, atrogin-1, MuRF1) that break down muscle tissue during caloric restriction. Users combining GH peptides with GLP-1s can maintain muscle at the lower end of the protein range (1.6g/kg) rather than requiring the higher end (2.2g/kg), making adherence significantly easier.
Protein Sources and Timing
- Eggs and egg whites (easy to eat when nauseous)
- Greek yogurt (high density, soft texture)
- Protein isolate shakes (concentrated, low volume)
- Chicken breast, fish (lean, high protein density)
- Cottage cheese (slow-digesting, filling)
- Morning (post-injection GH window): 40–60g protein
- Post-workout: 30–40g within 45 minutes
- Evening (before last meal): 20–30g protein
- Distribute remaining protein across 2–3 other meals
- Total: 4–5 protein feedings per day
Training During a Peptide Cut
Resistance training is non-negotiable for muscle preservation during fat loss — particularly on GLP-1 protocols. Mechanical load signals to muscle tissue that it is needed, which activates anti-catabolic pathways that override the muscle-breakdown signals from caloric restriction. Even 2–3 days per week of compound resistance training (squats, deadlifts, rows, presses) is sufficient to preserve the vast majority of lean mass during aggressive weight loss. Combining this with adequate protein and the anti-catabolic signaling of GH peptides produces the best possible body composition outcome during fat loss.
The Weight Loss Plateau Problem
Weight loss plateaus are almost universal in long-term fat loss protocols — including peptide-assisted ones. Understanding what a plateau actually represents versus a temporary fluctuation is critical before making any protocol changes.
True Plateau vs. Temporary Fluctuation
A true plateau is 3–4 weeks of no progress in body weight AND no change in body composition measurements (waist, hip, limb circumference). A temporary fluctuation is 1–2 weeks of scale stagnation that often accompanies muscle gain (which is denser than fat), water retention from higher carbohydrate intake, or hormonal fluctuations. The mistake is treating a 2-week scale stall as a plateau and making unnecessary protocol changes.
- • Scale weight stagnant 1–2 weeks
- • Measurements still improving
- • Clothes fitting better
- • Higher carb or sodium intake recently
- • No weight change 3–4+ weeks
- • Measurements also stagnant
- • Diet and training consistent
- • Energy lower, hunger returning
Plateau-Breaking Strategies
If on semaglutide or tirzepatide, titrate up by one dose level. GLP-1 appetite suppression effect partially wanes at a given dose over time as receptor sensitivity adapts — moving to the next dose tier restores the caloric deficit.
Rotating injection sites (abdomen, thigh, upper arm) prevents localized subcutaneous tissue changes that can affect absorption rate. Users who inject only in the same site can develop lipodystrophy that reduces peptide bioavailability.
If using GLP-1 only, adding CJC-1295/Ipamorelin introduces a second fat loss mechanism (direct lipolysis via GH) that works independently of appetite. This synergy reliably breaks GLP-1-only plateaus.
A structured diet break — eating at maintenance calories for 1–2 weeks — resets leptin levels and reverses adaptive thermogenesis (the metabolic slow-down response to prolonged deficit). After the break, fat loss accelerates significantly.
If on semaglutide and plateaued at maximum dose, switching to tirzepatide activates the additional GIP receptor pathway and reliably produces further weight loss. Tirzepatide → Retatrutide represents the next step for those who plateau on tirzepatide.
GLP-1 Receptor Agonists
Fastest fat loss — clinically proven appetite suppression
Mimic GLP-1, a gut hormone that slows gastric emptying, suppresses appetite, and improves insulin sensitivity. Originally developed for type 2 diabetes, now the most potent fat-loss tool available.
Growth Hormone Secretagogues
Body recomposition — burn fat while preserving or building muscle
Stimulate the pituitary to release more GH during sleep. GH is directly lipolytic — it mobilizes stored fat for energy while simultaneously preserving lean muscle. Best for body recomposition rather than pure weight loss.
GLP-1 vs GH Peptides vs Stack
| Feature | GLP-1 Peptides | GH Secretagogues | Combined Stack |
|---|---|---|---|
| Average Fat Loss | 15–29% body weight | 5–15% body fat | 20–30% body weight + muscle gain |
| Speed of Results | Rapid (weeks 4–8) | Gradual (months 2–4) | Rapid fat loss + slow muscle gain |
| Muscle Preservation | ⚠️ Risk of muscle loss | ✅ Preserves and builds muscle | ✅ Best muscle preservation |
| Dosing Frequency | Once weekly | Daily (before bed) | Both schedules combined |
| GI Side Effects | ⚠️ Nausea, constipation common | ✅ Minimal | ⚠️ From GLP component |
| Sleep Quality | Neutral | ✅ Dramatically improved | ✅ Improved |
| Best For | Pure weight loss goal | Body recomp + performance | Maximum results if motivated |
Weight Loss Peptide FAQ
What is the best peptide for weight loss?+
For pure weight loss, tirzepatide and retatrutide currently show the most dramatic clinical results (22–29% body weight reduction in trials). For body recomposition — losing fat while preserving or building muscle — CJC-1295 Ipamorelin is the gold standard. For maximum results, some advanced users combine GLP-1s with GH peptides, using the GLP for fat loss and the GH peptide to protect lean mass.
How do GLP-1 peptides cause weight loss?+
GLP-1 receptor agonists (semaglutide, tirzepatide, retatrutide) mimic GLP-1, a hormone produced in the gut after eating. They slow gastric emptying (food leaves the stomach more slowly, keeping you fuller longer), reduce appetite signals in the brain's hunger centers, and improve insulin sensitivity. The result is a significant reduction in caloric intake without the hunger or deprivation of traditional dieting.
Do peptides cause muscle loss during weight loss?+
GLP-1 peptides can cause muscle loss if protein intake is low — studies show roughly 25–40% of weight lost on GLP-1 drugs alone is lean mass, not fat. This is why combining a GLP-1 with CJC-1295 Ipamorelin (to stimulate GH and preserve muscle) and maintaining high protein intake (0.8g+ per pound of bodyweight) is increasingly recommended. GH secretagogues alone (without GLP-1) do not cause muscle loss.
How long does it take for weight loss peptides to work?+
GLP-1 peptides: appetite suppression begins within 1–2 weeks; meaningful weight loss visible at 4–8 weeks; maximum results at 6–12 months. GH secretagogues (CJC-1295/Ipamorelin): sleep improvement within 1–2 weeks; body composition changes visible at 6–8 weeks; peak recomposition at 3–6 months.
Can I take CJC-1295 Ipamorelin and semaglutide together?+
Yes — this combination is increasingly popular. Semaglutide drives the caloric deficit through appetite suppression; CJC-1295 Ipamorelin protects lean muscle and improves sleep. They work through completely different pathways with no negative interaction. This stack is particularly valuable for people concerned about muscle loss from GLP-1 monotherapy.
Does the weight lost on GLP-1 peptides come back after stopping?+
Weight regain after stopping GLP-1 peptides is a real and well-documented phenomenon. Clinical data shows that most patients regain a significant portion of lost weight within 12 months of discontinuation — the underlying hormonal drive toward weight gain (reduced satiety signaling, metabolic adaptation) resumes. This does not mean GLP-1s are not worth using — the metabolic improvements achieved (reduced visceral fat, improved insulin sensitivity, cardiovascular risk reduction) have lasting value. The most effective strategy is transitioning to a lower maintenance dose after reaching goal weight, rather than full cessation.
Are there peptides for weight loss without hormonal disruption?+
Yes — GH secretagogues (CJC-1295/Ipamorelin) and MOTS-c are the cleanest options. They produce fat loss without affecting sex hormones (testosterone, estrogen, progesterone), thyroid, or adrenal function. GLP-1 peptides also have no androgenic or estrogenic activity — they affect only the GLP-1 receptor system related to appetite and insulin. None of the common weight loss peptides cause hormonal disruption in the traditional sense.
Can peptide weight loss help with sleep apnea?+
Yes — there is meaningful evidence here. GLP-1 peptides reduce airway fat deposits and adipose tissue around the throat, which directly reduces sleep apnea severity. The SURMOUNT-OSA trial specifically demonstrated that tirzepatide significantly reduced the Apnea-Hypopnea Index (AHI) in obese patients with sleep apnea — by up to 55% in some groups. GH peptides improve sleep architecture independently by deepening slow-wave sleep, which benefits all sleep disorders. For obese individuals with sleep apnea, the GLP-1 class produces the most clinically significant improvement.
Shop Weight Loss Peptides
Semaglutide, tirzepatide, retatrutide, CJC-1295 Ipamorelin — COA verified, US domestic.